Portable MR Imaging System™ brings the power and specificity of MRI to a patient's bedside.
Chief Financial Officer of Santa Cruz Nutritionals
John was previously Chief Financial Officer of Acutus Medical, an arrhythmia care company that develops distinct, innovative technologies to provide physicians and patients with improved results. He has more than 20 years of experience leading financing and accounting in the health and medical device spaces.
Ruth brings more than 15 years of leadership experience in executive and human resource management for a variety of industries and Fortune 500 companies. Ms. Fattori serves on the board of directors of Quantum-Si, which created the world’s first next-generation protein sequencing platform.
Scott has played a key role in more than 20 medtech start-up, growth, and public companies with market valuations totaling over $20 billion, that cumulatively have delivered therapeutics and diagnostics to more than 20 million patients. Mr. Huennekens has been named Ernst & Young Entrepreneur of the Year in 2010 and was recognized by Goldman Sachs in 2016, 2017, and 2018 as one of their 100 Most Intriguing Entrepreneurs.
Jonathan is a serial entrepreneur with more than 20 years of experience who founded and invented massively parallel DNA sequencing, semiconductor sequencing, and ultrasound-on-a-chip (Butterfly Network). In 2016, he was awarded the National Medal of Technology and Innovation for his “pioneering inventions and commercialization of next-generation DNA sequencing technologies, making access to genomic information easier, faster, and more cost-effective for researchers around the world.”
President and CEO
Twenty-five years building and leading teams at digital surgery, digital health ecosystem, surgical robotics, and medical imaging and diagnostic startups and Fortune 500 companies, including Apple, Verb Surgical, Abbott Medical Optics, OptiMedica, Intuitive Surgical, Xradia, and Varioscale. Awarded patents in x-ray imaging, medical endoscopy, and laser surgery applications. University of Kansas BS; University of Colorado, Boulder MS.
Chief Financial Officer
Twenty years experience in the financial and banking industry with a prior background in manufacturing systems and mechanical engineering. Previous leadership experience with Halio Inc., Mizuho Securities, and Citigroup. UCLA Anderson School of Management MBA in Banking, Corporate, Finance, and Securities Law.
Chief Product Officer
Formerly head of Surgical and Implantable Devices and founding member of Verily Life Science, formerly known as Google Life Sciences. Expertise in medical devices, medtech, and imaging. Senior positions at Google, Abbott Medical Optics, Proximie, and OptiMedica. Patents and publications in medical imaging, medical image processing, intraoperative imaging, surgical technology, and surgical workflow optimization. UC Berkeley and UC San Francisco PhD in Bioengineering. Georgia Institute of Technology BS in Biomedical Engineering.
Khan Siddiqui, M.D.
Chief Medical Officer / Chief Strategy Officer
Serial entrepreneur; board-certified radiologist with leadership experience at Johns Hopkins University and University of Maryland; American College of Radiology Informatics Commission; Microsoft R&D leader; Founder, CTO, and Chief Medical Officer of higi.
World’s first FDA-cleared portable MRI expands leading neurosurgery suite’s tech capabilities for novel diagnostic and therapeutic approaches GUILFORD, Conn. and MINNEAPOLIS, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine”), creator of the first U.S....
GUILFORD, Conn., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that created Swoop®, the world's first FDA-cleared portable MRI system™, today announced preliminary unaudited revenue for the fourth quarter and full year ended December 31, 2021....
- Business combination results in over $160 million in gross cash proceeds to Hyperfine - Funds to catalyze commercial expansion of the world's first FDA-cleared portable MRI system™ and additional organic growth initiatives - Hyperfine to begin trading on Nasdaq under ticker "HYPR" GUILFORD, Conn....
(GUILFORD, CT – December 13, 2021) Hyperfine Inc., creator of Swoop ® , the first FDA-cleared portable magnetic resonance imaging TM (MRI) device, today announced the Board of Directors that will serve subsequent to the closing of the previously announced business combination between Hyperfine,...